| Primary |
| Ill-defined Disorder |
25.3% |
| Neuralgia |
19.0% |
| Epilepsy |
8.9% |
| Drug Use For Unknown Indication |
6.3% |
| Pain |
6.3% |
| Convulsion |
3.8% |
| Fibromyalgia |
3.8% |
| Partial Seizures |
3.8% |
| Post Herpetic Neuralgia |
3.8% |
| Back Pain |
2.5% |
| Complex Partial Seizures |
2.5% |
| Guillain-barre Syndrome |
2.5% |
| Neuropathy |
2.5% |
| Abdominal Pain |
1.3% |
| Complex Regional Pain Syndrome |
1.3% |
| Device Related Infection |
1.3% |
| Diabetic Neuropathy |
1.3% |
| Neck Pain |
1.3% |
| Neuropathy Peripheral |
1.3% |
| Pain In Extremity |
1.3% |
|
| Somnolence |
15.9% |
| Depression |
9.1% |
| Tremor |
6.8% |
| Urinary Retention |
6.8% |
| Nervous System Disorder |
4.5% |
| Oedema Peripheral |
4.5% |
| Pain |
4.5% |
| Partial Seizures |
4.5% |
| Psychotic Disorder |
4.5% |
| Rectal Haemorrhage |
4.5% |
| Serotonin Syndrome |
4.5% |
| Sinus Bradycardia |
4.5% |
| Speech Disorder |
4.5% |
| Vomiting |
4.5% |
| Weight Increased |
4.5% |
| Angioneurotic Oedema |
2.3% |
| Aphasia |
2.3% |
| Breast Swelling |
2.3% |
| Dizziness |
2.3% |
| Dry Mouth |
2.3% |
|
| Secondary |
| Product Used For Unknown Indication |
39.4% |
| Drug Use For Unknown Indication |
18.3% |
| Central Pain Syndrome |
5.5% |
| Epilepsy |
5.5% |
| Pain |
4.6% |
| Trigeminal Neuralgia |
4.6% |
| Blood Cholesterol Increased |
3.7% |
| Myocardial Infarction |
3.7% |
| Suicide Attempt |
3.7% |
| Neuralgia |
2.8% |
| Pain In Extremity |
1.8% |
| Schizophrenia |
1.8% |
| Diabetes Mellitus |
0.9% |
| Diabetic Neuropathy |
0.9% |
| Exposure During Pregnancy |
0.9% |
| Ill-defined Disorder |
0.9% |
| Intermittent Claudication |
0.9% |
|
| Myocardial Infarction |
10.0% |
| Unresponsive To Stimuli |
10.0% |
| Respiratory Arrest |
6.7% |
| Single Functional Kidney |
6.7% |
| Suicidal Ideation |
6.7% |
| Thrombocythaemia |
6.7% |
| Toxicity To Various Agents |
6.7% |
| Trigeminal Neuralgia |
6.7% |
| Atrioventricular Block Complete |
3.3% |
| Cardio-respiratory Arrest |
3.3% |
| Completed Suicide |
3.3% |
| Condition Aggravated |
3.3% |
| Cytotoxic Oedema |
3.3% |
| Diabetic Foot |
3.3% |
| Exposure Via Ingestion |
3.3% |
| Foetal Malformation |
3.3% |
| Generalised Anxiety Disorder |
3.3% |
| Intentional Self-injury |
3.3% |
| Neuroleptic Malignant Syndrome |
3.3% |
| Neutropenia |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
13.4% |
| Depression |
12.6% |
| Pain |
9.2% |
| Neuropathy |
5.9% |
| Acute Myeloid Leukaemia |
5.0% |
| Neuralgia |
5.0% |
| Osteoporosis |
5.0% |
| Bipolar Disorder |
4.2% |
| Cardiac Failure |
4.2% |
| Colorectal Cancer Metastatic |
3.4% |
| Drug Use For Unknown Indication |
3.4% |
| Fibromyalgia |
3.4% |
| Hypertension |
3.4% |
| Multiple Myeloma |
3.4% |
| Multiple Sclerosis |
3.4% |
| Narcolepsy |
3.4% |
| Restless Legs Syndrome |
3.4% |
| Yolk Sac Tumour Site Unspecified |
3.4% |
| Breast Cancer |
2.5% |
| Central Pain Syndrome |
2.5% |
|
| Pneumonia |
9.2% |
| Somnolence |
9.2% |
| Pain |
7.7% |
| Vomiting |
7.7% |
| Pharmaceutical Product Complaint |
6.2% |
| Pyrexia |
6.2% |
| Syncope |
6.2% |
| Fall |
4.6% |
| Tremor |
4.6% |
| Urticaria |
4.6% |
| Ventricular Hypertrophy |
4.6% |
| Weight Decreased |
4.6% |
| Dyskinesia |
3.1% |
| Grand Mal Convulsion |
3.1% |
| Hypertension |
3.1% |
| Insomnia |
3.1% |
| Melaena |
3.1% |
| Nausea |
3.1% |
| Prescribed Overdose |
3.1% |
| Renal Pain |
3.1% |
|
